Lam Research Co. (NASDAQ:LRCX) Shares Bought by Baldwin Wealth Partners LLC MA

Baldwin Wealth Partners LLC MA lifted its holdings in shares of Lam Research Co. (NASDAQ:LRCX) by 3,451.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,232 shares of the semiconductor company’s stock after buying an additional 3,141 shares during the period. Baldwin Wealth Partners LLC MA’s holdings in Lam Research were worth $233,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Atwood & Palmer Inc. acquired a new position in Lam Research during the 4th quarter worth $27,000. West Oak Capital LLC lifted its holdings in Lam Research by 50.9% in the fourth quarter. West Oak Capital LLC now owns 400 shares of the semiconductor company’s stock worth $29,000 after purchasing an additional 135 shares during the period. Finley Financial LLC bought a new position in Lam Research in the 4th quarter valued at about $30,000. Householder Group Estate & Retirement Specialist LLC increased its stake in Lam Research by 159.1% during the 4th quarter. Householder Group Estate & Retirement Specialist LLC now owns 500 shares of the semiconductor company’s stock valued at $36,000 after buying an additional 307 shares during the period. Finally, Laurel Wealth Advisors LLC bought a new stake in shares of Lam Research during the 4th quarter worth about $37,000. 84.61% of the stock is owned by institutional investors.

Analyst Ratings Changes

LRCX has been the subject of several recent analyst reports. KeyCorp upgraded shares of Lam Research from a “sector weight” rating to an “overweight” rating and set a $95.00 price objective for the company in a report on Friday, January 17th. Morgan Stanley lifted their price target on Lam Research from $76.00 to $78.00 and gave the company an “equal weight” rating in a research report on Thursday, December 5th. Stifel Nicolaus restated a “buy” rating and issued a $100.00 price objective (down previously from $105.00) on shares of Lam Research in a report on Thursday, October 24th. B. Riley reduced their target price on shares of Lam Research from $132.50 to $105.00 and set a “buy” rating for the company in a research note on Wednesday, October 23rd. Finally, Wolfe Research lowered Lam Research from an “outperform” rating to a “peer perform” rating in a report on Wednesday, January 15th. Nine research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $95.77.

Lam Research Trading Down 5.1 %

NASDAQ:LRCX opened at $75.64 on Tuesday. The company has a current ratio of 2.53, a quick ratio of 1.74 and a debt-to-equity ratio of 0.53. Lam Research Co. has a 1-year low of $68.87 and a 1-year high of $113.00. The firm has a market capitalization of $97.32 billion, a price-to-earnings ratio of 24.45, a PEG ratio of 1.53 and a beta of 1.45. The business’s 50-day moving average price is $75.43 and its two-hundred day moving average price is $79.63.

Lam Research Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, January 8th. Investors of record on Wednesday, December 11th were given a $0.23 dividend. The ex-dividend date of this dividend was Wednesday, December 11th. This represents a $0.92 dividend on an annualized basis and a dividend yield of 1.22%. Lam Research’s dividend payout ratio is 29.77%.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.